Schering buys new contraception delivery methods
This article was originally published in Clinica
Executive Summary
German pharmaceutical and contrast media manufacturer Schering is to purchase Leiras for DM 466 million ($307 million). The subsidiary of Finnish company Huhtamaki, Leiras manufactures gynaecology, oncology and ophthalmology products and had revenues of $190 million last year. The ophthalmology business is not part of the purchase and will be sold separately later this year.